BPH Energy Limited

MEC Resources Limited (ASX:MMR) investee company Advent Energy Ltd (Advent) has advised that it (through wholly owned subsidiary Asset Energy Pty Ltd) has taken operational control of the Ocean Patriot semi-submersible drilling rig overnight.

MEC Resources Limited (ASX:MMR) has been advised by its investee company Advent Energy Limited (Advent Energy) that it has received updated advice as to operational handover of the Ocean Patriot semisubmersible drilling rig.

Bounty Oil & Gas NL (ASX:BUY) is pleased to update progress on timing for the New Seaclem 1 well in PEP 11, offshore Sydney Basin.

MEC Resources (ASX:MMR) is pleased to announce that it has been informed by its investee company Advent Energy Ltd, that it has received a provisional date of Tuesday 7 December 2010 for the commencement of the operational handover of the Ocean Patriot Drilling semi-submersible rig for drilling the PEP11 project offshore Sydney.

In response to a number of queries from Shareholders BPH Corporate Limited (ASX:BPH) is pleased to provide further details on the current capital raising announced 19 November 2010.

MEC Resources (ASX:MMR) is pleased to announce that second independent report finds PEP11 New Seaclem-1 Well Gas "Highly Likely" MEC investee company, Advent Energy Ltd ("Advent") is pleased to advise that it has received and reviewed a report from global geoscientific and environmental consultants RPS Group (RPS) describing gas as "highly likely "at the target drilling depths for the New Seaclem-1 Well.

MEC Resources (ASX:MMR) is pleased to advise that Advent Energy has received approval from Industry & Investment NSW (I&I NSW) for the drilling of New Seaclem-1, offshore Newcastle, NSW. The NSW Department of Industry & Investment trades as Industry & Investment NSW (I&I NSW).

BPH Corporate Limited (ASX:BPH) is pleased to provide an update regarding its investee company Advent Energy Ltd's capital raising program and planned drilling activities within PEP11, offshore NSW.

An Australian invention designed to decrease the likelihood of patients remembering parts of their surgery and improve their recovery from anaesthesia has just completed a further stage of clinical trials at Royal Melbourne Hospital. The positive results following the completion of this trial are a significant development for BioPharmica's investee Cortical Dynamics.